Inhibition of Bcl-6 Expression Ameliorates Asthmatic Characteristics in Mice
The function of Bcl-6 in T follicular helper (Tfh) cell maturation is indispensable, and Tfh cells play a pivotal role in asthma. This study investigated the impact of Bcl-6 on asthmatic traits.
The microscopic pathological alterations, airway resistance (AR), and lung compliance (LC) were determined in asthmatic mice and Bcl-6 interference mice. The surface molecular markers of Tfh cells and the Bcl-6 mRNA and protein expression were determined by flow cytometry, RT-qPCR, and Western blotting, respectively. The relationships between the Tfh cell ratio and the IgE and IgG 1 concentrations in peripheral blood mononuclear cells (PBMCs) and bronchoalveolar lavage fluid (BALF) were determined.
Asthmatic inflammatory changes were observed in the lung tissue and were attenuated by Bcl-6 siRNA and dexamethasone (DXM). Asthmatic mice exhibited an increased AR and a decreased LC, while Bcl-6 siRNA or DXM mitigated these changes. The percentages of Tfh cells and eosinophils were significantly increased in the asthmatic mice, and they significantly decreased after Bcl-6 inhibition or DXM treatment. RT-qPCR and Western blotting analyses revealed that the Bcl-6 expression level in PBMCs was significantly higher in asthmatic mice, and it decreased following Bcl-6 inhibition or DXM treatment. The IgE expression in the serum and BALF and the B cell expression in PBMCs exhibited a similar trend. In asthmatic mice, the ratio of Tfh cells in the peripheral blood showed a strong positive correlation with the IgE levels in the serum and BALF, but not with the IgG 1 levels.
The amelioration of airway inflammation and airway hyper-responsiveness is achieved through Bcl-6 suppression, which effectively hinders Tfh cell differentiation, ultimately resulting in a concurrent reduction in IgE production.
Bcl-6 / Tfh / asthma / airway hyper-responsiveness / mouse model
[1] | Lemanske RF Jr, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol, 2010,125(2 Suppl 2):S95–S102 |
[2] | Papi A, Brightling C, Pedersen SE, et al. Asthma. Lancet, 2018,391(10122):783–800 |
[3] | Balaha MF, Tanaka H, Yamashita H, et al. Oral Nigella sativa oil ameliorates ovalbumin-induced bronchial asthma in mice. Int Immunopharmacol, 2012,14(2):224–231 |
[4] | Park HJ, Lee CM, Jung ID, et al. Quercetin regulates Th1/Th2 balance in a murine model of asthma. Int Immunopharmacol, 2009,9(3):261–267 |
[5] | Schaerli P, Willimann K, Lang AB, et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med, 2000,192(11):1553–1562 |
[6] | Breitfeld D, Ohl L, Kremmer E, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med, 2000,192(11):1545–1552 |
[7] | Vinuesa CG, Linterman MA, Yu D, et al. Follicular Helper T Cells. Annu Rev Immunol, 2016,34:335–368 |
[8] | Qi H. T follicular helper cells in space-time. Nat Rev Immunol, 2016,16(10):612–625 |
[9] | Deng J, Wei Y, Fonseca VR, et al. T follicular helper cells and T follicular regulatory cells in rheumatic diseases. Nat Rev Rheumatol, 2019,15(8):475–490 |
[10] | Akdis CA, Arkwright PD, Bruggen MC, et al. Type 2 immunity in the skin and lungs. Allergy, 2020,75(7):1582–1605 |
[11] | Duan YQ, Xia MH, Ren L, et al. Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients. Curr Med Sci, 2020,40(4):618–624 |
[12] | Xie NN, Zhang WC, Chen J, et al. Clinical Characteristics, Diagnosis, and Therapeutics of COVID-19: A Review. Curr Med Sci, 2023,43(6):1066–1074 |
[13] | Johnston RJ, Poholek AC, DiToro D, et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science, 2009,325(5943):1006–1010 |
[14] | Hu Y, Yu S, He J, et al. T follicular helper cells in peripheral blood are associated with the expression of B cells and plasma IgE level in patients with acute asthma exacerbation. Int J Clin Exp Med, 2017,10(1):1484–1489 |
[15] | Xin N, Fu L, Shao Z, et al. RNA interference targeting Bcl-6 ameliorates experimental autoimmune myasthenia gravis in mice. Mol Cell Neurosci, 2014,58:85–94 |
[16] | Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 2001,25(4):402–408 |
[17] | Zhang X, Ing S, Fraser A, et al. Follicular helper T cells: new insights into mechanisms of autoimmune diseases. Ochsner J, 2013,13(1):131–139 |
[18] | Mintz MA, Cyster JG. T follicular helper cells in germinal center B cell selection and lymphomagenesis. Immunol Rev, 2020,296(1):48–61 |
[19] | Choi YS, Yang JA, Crotty S. Dynamic regulation of Bcl6 in follicular helper CD4 T (Tfh) cells. Curr Opin Immunol, 2013,25(3):366–372 |
[20] | Linterman MA, Vinuesa CG. T follicular helper cells during immunity and tolerance. Prog Mol Biol Transl Sci, 2010,92:207–248 |
[21] | Vogelzang A, McGuire HM, Yu D, et al. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity, 2008,29(1):127–137 |
[22] | Crotty S. T Follicular Helper Cell Biology: A Decade of Discovery and Diseases. Immunity, 2019,50(5):1132–1148 |
[23] | Choi YS, Kageyama R, Eto D, et al. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity, 2011,34(6):932–946 |
[24] | Xu H, Li X, Liu D, et al. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature, 2013,496(7446):523–527 |
[25] | Weber JP, Fuhrmann F, Feist RK, et al. ICOS maintains the T follicular helper cell phenotype by down-regulating Kruppel-like factor 2. J Exp Med, 2015,212(2):217–233 |
[26] | Hatzi K, Nance JP, Kroenke MA, et al. BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms. J Exp Med, 2015,212(4):539–553 |
[27] | Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity, 2014,41(4):529–542 |
[28] | Spits H, Artis D, Colonna M, et al. Innate lymphoid cells— a proposal for uniform nomenclature. Nat Rev Immunol, 2013,13(2):145–149 |
[29] | Deckers J, Branco Madeira F, Hammad H. Innate immune cells in asthma. Trends Immunol, 2013, 34(11):540–547 |
[30] | Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol, 2012,30:647–475 |
[31] | Froidure A, Mouthuy J, Durham SR, et al. Asthma phenotypes and IgE responses. Eur Respir J, 2016,47(1):304–319 |
[32] | Choi J, Diao H, Faliti CE, et al. Bcl-6 is the nexus transcription factor of T follicular helper cells via repressor-of-repressor circuits. Nat Immunol, 2020,21(7):777–789 |
[33] | Gong F, Zheng T, Zhou P. T Follicular Helper Cell Subsets and the Associated Cytokine IL-21 in the Pathogenesis and Therapy of Asthma. Front Immunol, 2019,10:2918 |
[34] | Gowthaman U, Chen JS, Zhang B, et al. Identification of a T follicular helper cell subset that drives anaphylactic IgE. Science, 2019,365(6456):eaaw6433 |
[35] | Nials AT, Uddin S. Mouse models of allergic asthma: acute and chronic allergen challenge. Dis Model Mech, 2008,1(4–5):213–220 |
[36] | Craft JE. Follicular helper T cells in immunity and systemic autoimmunity. Nat Rev Rheumatol, 2012,8(6):337–347 |
[37] | Ise W, Kohyama M, Schraml BU, et al. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat Immunol, 2011,12(6):536–543 |
[38] | Kroenke MA, Eto D, Locci M, et al. Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation. J Immunol, 2012,188(8):3734–3744 |
[39] | Lahmann A, Kuhrau J, Fuhrmann F, et al. Bach2 Controls T Follicular Helper Cells by Direct Repression of Bcl-6. J Immunol, 2019,202(8):2229–2239 |
/
〈 | 〉 |